| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |